Ashwani Gujral of ashwanigujral.com recommends buying Indraprastha Medical and advises selling Indo Count Industries and Cairn India.
CA Rudramurthy BV of Vachana Investments is of the view that one may buy Aurobindo Pharma with a target of Rs 780.
Manish Sharma of Derivative Trading Research recommends selling Ceat with a target of Rs 970 and Amara Raja with a target of Rs 840.
Sharmila Joshi, Market Expert advises buying Biocon with a target of Rs 478.
SP Tulsian of sptulsian.com feels that Indraprastha Medical Corporation can move to about Rs 40 maybe in six months. "It has 700 beds hospital in Delhi, which is one of the largest hospitals in the country and they have the capacity to expand to 1,000 beds as well," he adds.
SP Tulsian of sptulsian.com asks traders to keep a view of about six months and look for a target of Rs 500 on Torrent Pharmaceuticals. He expects Indraprastha Medical Corporation, which is now ruling at around Rs 33, to move to Rs 40 maybe in six months or so.
Indraprastha Medical can move to Rs 50 in next twelve months, says SP Tulsian, sptulsian.com.
Hold Indraprastha Medical Corporation for long term, says Aashish Tater, Head of Research, Fort Share Broking.